CN102516236A - 抗精神分裂症药物伊潘立酮的制备方法 - Google Patents
抗精神分裂症药物伊潘立酮的制备方法 Download PDFInfo
- Publication number
- CN102516236A CN102516236A CN2011103690147A CN201110369014A CN102516236A CN 102516236 A CN102516236 A CN 102516236A CN 2011103690147 A CN2011103690147 A CN 2011103690147A CN 201110369014 A CN201110369014 A CN 201110369014A CN 102516236 A CN102516236 A CN 102516236A
- Authority
- CN
- China
- Prior art keywords
- preparation
- formula
- zomaril
- ethyl ketone
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110369014.7A CN102516236B (zh) | 2011-11-18 | 2011-11-18 | 抗精神分裂症药物伊潘立酮的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110369014.7A CN102516236B (zh) | 2011-11-18 | 2011-11-18 | 抗精神分裂症药物伊潘立酮的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102516236A true CN102516236A (zh) | 2012-06-27 |
CN102516236B CN102516236B (zh) | 2014-05-07 |
Family
ID=46287358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110369014.7A Active CN102516236B (zh) | 2011-11-18 | 2011-11-18 | 抗精神分裂症药物伊潘立酮的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102516236B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796090A (zh) * | 2012-08-30 | 2012-11-28 | 天津华津制药有限公司 | 一种伊潘立酮的制备方法 |
CN103319472A (zh) * | 2013-07-23 | 2013-09-25 | 河北科技大学 | 一种伊潘立酮的制备方法 |
CN107513060A (zh) * | 2017-09-22 | 2017-12-26 | 山东金城医药化工有限公司 | 伊潘立酮的合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950674A (en) * | 1985-12-20 | 1990-08-21 | A. H. Robins Company, Incorporated | Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment |
CN1136275A (zh) * | 1993-10-28 | 1996-11-20 | 赫彻斯特-柔斯尔药物公司 | 芳杂环基哌啶类、吡咯烷类及哌嗪类及其作为抗精神病药和止痛药的用途 |
CN101768154A (zh) * | 2009-09-19 | 2010-07-07 | 浙江华海药业股份有限公司 | 一种新的依潘立酮的制备方法 |
-
2011
- 2011-11-18 CN CN201110369014.7A patent/CN102516236B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950674A (en) * | 1985-12-20 | 1990-08-21 | A. H. Robins Company, Incorporated | Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment |
CN1136275A (zh) * | 1993-10-28 | 1996-11-20 | 赫彻斯特-柔斯尔药物公司 | 芳杂环基哌啶类、吡咯烷类及哌嗪类及其作为抗精神病药和止痛药的用途 |
CN101768154A (zh) * | 2009-09-19 | 2010-07-07 | 浙江华海药业股份有限公司 | 一种新的依潘立酮的制备方法 |
Non-Patent Citations (2)
Title |
---|
李陈: "伊潘立酮合成缩合反应的工艺改进", 《辽宁化工》 * |
王媛等: "表面活性剂在制药工业中的应用", 《精细化工》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796090A (zh) * | 2012-08-30 | 2012-11-28 | 天津华津制药有限公司 | 一种伊潘立酮的制备方法 |
CN102796090B (zh) * | 2012-08-30 | 2015-03-25 | 天津华津制药有限公司 | 一种伊潘立酮的制备方法 |
CN103319472A (zh) * | 2013-07-23 | 2013-09-25 | 河北科技大学 | 一种伊潘立酮的制备方法 |
CN103319472B (zh) * | 2013-07-23 | 2016-07-06 | 河北科技大学 | 一种伊潘立酮的制备方法 |
CN107513060A (zh) * | 2017-09-22 | 2017-12-26 | 山东金城医药化工有限公司 | 伊潘立酮的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102516236B (zh) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102391267A (zh) | 8-(3-氨基-哌啶-1-基)-黄嘌呤、其制备方法及其用途 | |
TW200932749A (en) | Process improvement using TMEDA | |
CN103664912B (zh) | 一种普卡必利的合成工艺 | |
CN101768154A (zh) | 一种新的依潘立酮的制备方法 | |
CN110698467B (zh) | 恩格列净的合成方法 | |
CN104177395B (zh) | 一种苯炔前体及其合成方法 | |
CN102516236B (zh) | 抗精神分裂症药物伊潘立酮的制备方法 | |
CN103649081A (zh) | 合成利伐沙班中间体4-{4-[(5s)-5-(氨基甲基)-2-氧代-1,3-恶唑烷-3-基]苯基}吗啉-3-酮的新方法 | |
CN102395582A (zh) | 伊潘立酮的一种制备方法及结晶方法 | |
CN107365296A (zh) | 作为ev71和cav16病毒抑制剂的吡啶咪唑酮衍生物的制备方法 | |
CN105859686A (zh) | 一种高纯度达比加群酯的制备工艺 | |
CN109096119B (zh) | 一种制备盐酸西那卡塞的方法 | |
CN101638406B (zh) | 邻-羟甲基苯甲酸内酯的制备方法 | |
CN102675294A (zh) | 一种合成氯沙坦及其中间体的方法 | |
CN109912526A (zh) | 制造噁唑化合物的方法 | |
CN1680330A (zh) | 一种(r)-(-)-阿朴吗啡的制备方法 | |
CN104672180B (zh) | 一种[(1s)‑3‑甲基‑1‑[[(2r)‑2‑甲基环氧乙基]羰基]丁基]氨基甲酸叔丁酯的手性制备方法 | |
CN101391969A (zh) | N-甲基-2-(2,4-二氯苯氧基)乙酰胺的制备方法 | |
CN106220617A (zh) | 一种达卡他韦的合成新方法 | |
CN108101899B (zh) | IDO1抑制剂Epacadostat中间体的制备方法 | |
CN105924400A (zh) | 阿齐沙坦杂质a和b的制备方法 | |
CN101293856B (zh) | 一种抗氧抗铜剂的制备方法 | |
CN102617339A (zh) | 3-环丙基甲氧基-4-卤代苯甲酸或其衍生物及应用 | |
CN103880747B (zh) | 无定形托伐普坦的制备方法 | |
CN102643273B (zh) | 一种伊潘立酮的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 150025 Beijing Road, Limin Development Zone, Harbin, Heilongjiang Applicant after: MEDISAN PHARMACEUTICAL CO., LTD. HARBIN Address before: 150025 Beijing Road, Limin Development Zone, Harbin, Heilongjiang Applicant before: Medisan Pharmaceutical Co., Ltd., Harbin |
|
CB03 | Change of inventor or designer information |
Inventor after: Chen Zhongqiang Inventor after: Lv Min Inventor after: Jin Jinglong Inventor after: He Qin Inventor after: Ju Yanru Inventor after: Liu Liyan Inventor before: Chen Zhongqiang Inventor before: Lv Min Inventor before: Jin Jinglong Inventor before: He Qin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN ZHONGQIANG LV MIN JIN JINGLONG HE QIN TO: CHEN ZHONGQIANG LV MIN JIN JINGLONG HE QIN JU YANRU LIU LIYAN Free format text: CORRECT: APPLICANT; FROM: TRI-LION PHARMACEUTICAL CO., LTD., HARBIN TO: MEDISAN PHARMACEUTICAL CO.,LTD. HARBIN |
|
GR01 | Patent grant |